Manufacturer |
ProSci
|
Category |
|
Type |
Peptides |
Specific against |
other |
Format |
Liquid |
Applications |
Blocking |
Amount |
0.05 mg |
Item no. |
PRS-3531P-0.05mg |
eClass 6.1 |
34160400 |
eClass 9.0 |
32160409 |
Available |
|
Applications |
SARS envelope peptide is used for blocking the activity of the SARS envelope antibody. |
Applications |
SARS envelope peptide is used for blocking the activity of the SARS envelope antibody. |
Buffer |
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide |
Storage Conditions |
Store SARS Envelope peptide at -20˚ C, stable for one year. |
Disclaimer |
This product is for research use only. |
Concentration |
200 ug/mL |
Peptide Name |
SARS Envelope Peptide |
Location |
10 amino acids near the amino terminus of SARS E protein. |
Background References 1 |
Marra MA, Jones SJ, Astell CR, et al. The Genome sequence of the SARS-associated corona virus. Science 2003; 300:1399-404. |
Background References 2 |
Yonezawa K, Tokunaga C, Oshiro N, et al. Raptor, a binding partner of target of rapamycin. Biochem. Biophys. Res. Commun. 2004; 313:437-441. |
Background References 3 |
Hara K, Yonezawa K, Weng QP, et al. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 1998; 273:14484-94. |
Protein Gi # |
30173401 |
Accession # |
P59637 |
Ncbi Gene Id # |
1489671 |
Ncbi Official Symbol |
E |
Ncbi Official Full Name |
Envelope small membrane protein |
Ncbi Organism |
SARS coronavirus |
Swissprot # |
P59637 |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.